Latest filing published 30 Oct 2026 for Regeneron Pharmaceuticals, INC., €321k.
Insider track record
No signal scores available.
Guarini Kathryn: trading record in brief
All filings by Guarini Kathryn on record concern Regeneron Pharmaceuticals, Inc. Between 10 August 2026 and 30 October 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 30 October 2026 with a transaction (€321k) in Regeneron Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Guarini Kathryn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 shares@ US$900.00CommonSEC144:0001969223-26-001109
- 400 shares@ US$800.000.0004% mcap25.9% of flowCommonSEC144:0001969223-26-000870
2 of 2 declarations
